Litman Gregory Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Litman Gregory Wealth Management's PFE Position: Q4 2025 in Review
Litman Gregory Wealth Management held its Pfizer (PFE) position steady in Q4 2025 at 44,398 shares worth $1.11M. The position accounts for 0.08% of the portfolio, ranked #80.
Litman Gregory Wealth Management first reported a position in PFE in Q1 2016 and has held it in 24 quarters since. The position peaked at $1.13M in Q3 2025. 2,923 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Litman Gregory Wealth Management held 44,398 shares of Pfizer worth $1.11M as of Q4 2025.
- Litman Gregory Wealth Management left its Pfizer share count unchanged in Q4 2025.
- Pfizer made up 0.08% of Litman Gregory Wealth Management's portfolio in Q4 2025, its #80 holding.
- Litman Gregory Wealth Management first reported a position in Pfizer in Q1 2016 and has held it in 24 quarters since.
- Litman Gregory Wealth Management's Pfizer position peaked at $1.13M in Q3 2025.
- 2,923 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Litman Gregory Wealth Management's 13F filing for Q4 2025, filed 12 Feb 2026.